Back to search results

A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

Primary Membranous Nephropathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Research Site, Los Angeles, California, United States

  • Research Site, Iowa City, Iowa, United States

  • Research Site, Bethesda, Maryland, United States

  • Research Site, New York, New York, United States

  • Research Site, Houston, Texas, United States

  • Research Site, Houston, Texas, United States

  • Research Site, Ieper, Belgium

  • Research Site, Bordeaux, France

  • Research Site, Créteil, France

  • Research Site, Lyon, France

  • Research Site, Nantes, France

  • Research Site, Nîmes, France

  • Research Site, Düsseldorf, Germany

  • Research Site, Brescia, Italy

  • Research Site, Rozzano, Italy

  • Research Site, Torino, Italy

  • Research Site, Verona, Italy

  • Research Site, Lodz, Poland

  • Research Site, Barcelona, Spain

  • Research Site, Madrid, Spain

  • Research Site, London, United Kingdom

  • Research Site, Manchester, United Kingdom

View source on ClinicalTrials.gov(opens in a new tab)